Transcatheter valve-in-valve implantation vs. reoperative mitral valve surgery for failing surgical prosthesis

Abstract

The incidence of degenerated mitral bioprosthesis is increasing in clinical practice due to a greater use of biological prostheses for mitral valve replacement compared to mechanical valves and increased life expectancy after cardiac surgery. Similarly, mitral valve repair can result in long-term recurrence of mitral valve disease requiring reintervention. Therefore, the number of failing surgical prosthesis or repaired valves will increase over the next years representing a new challenge in the corrective approach in the case of long-term structural valve degeneration. Those patients were generally managed with reoperative mitral valve surgery, but transcatheter interventional therapies, initially considered an option in patients who are ineligible for redo surgery, have been recently associated with excellent outcomes. The efficacy and safety of transcatheter mitral valve procedures have been reported in both failing ring annuloplasty or degenerated mitral bioprosthesis, but the use of non-dedicated devices remains associated with significant severe complications such as device malpositioning or left ventricular outflow tract obstruction requiring emergent conversion to open surgery. Both the careful selection of patients and pre/intra-procedural scheduling are warranted to maximize benefits and reduce issues. This review focuses on emerging transcatheter mitral valve replacement devices as therapeutic options for degenerated mitral bioprosthesis or failed mitral repair. This paper aims to summarize current interventional techniques and available evidence, comparing outcomes between transcatheter technologies and reoperative mitral valve surgery.

Keywords

Mitral valve / regurgitation / ischemic mitral / transcatheter / replacement / repair

References

[1] Ejiofor JI,Ramirez-Del Val F.Outcomes of repeat mitral valve replacement in patients with prior mitral surgery: A benchmark for transcatheter approaches.J Thorac Cardiovasc Surg2018;156:619-27.e1

[2] Nappi F,Nenna A.Treatment options for ischemic mitral regurgitation: A meta-analysis.J Thorac Cardiovasc Surg2020:S0022-5223(20)31262

[3] Nappi F,Sing SSA.Mitral regurgitation: lessons learned from COAPT and MITRA-Fr.J Thorac Dis2020;12:2936-44 PMCID:PMC7330366

[4] Nappi F,Timofeeva I,Gentile F.Mitral regurgitation after transcatheter aortic valve replacement.J Thorac Dis2020;12:2926-35 PMCID:PMC7330403

[5] Vohra HA,Roubelakis A.Outcome after redo-mitral valve replacement in adult patients: a 10-year single-centre experience.Interact Cardiovasc Thorac Surg2012;14:575-9 PMCID:PMC3735849

[6] Bourguignon T,Loardi C.Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations.J Thorac Cardiovasc Surg2014;148:2004-11.e1

[7] Condado JF,Babaliaros V.Transcatheter mitral valve-in-valve therapy.Interv Cardiol Clin2016;5:117-23

[8] Nappi F,Padala M.The choice of treatment in ischemic mitral regurgitation with reduced left ventricular function.Ann Thorac Surg2019;108:1901-12 PMCID:PMC7424599

[9] Nappi F,Avtaar Singh SS,Chello M.Risk of ischemic mitral regurgitation recurrence after combined valvular and subvalvular repair.Ann Thorac Surg2019;108:536-43

[10] Elmariah S,Llanos A.First experience with transcatheter valve-in-valve implantation for a stenotic mitral prosthesis within the United States.JACC Cardiovasc Interv2012;5:e13-4

[11] Coylewright M,Malouf JA.Percutaneous mitral valve replacement using a transvenous, transseptal approach: transvenous mitral valve replacement.JACC Cardiovasc Interv2015;8:850-7

[12] Nappi F,Sablayrolles JL.Pushing the limits in transcatheter aortic valve replacement: High-volume center's effect, overconfidence, or something else?.JACC Cardiovasc Interv2016;9:2186-8

[13] Sorajja P,Vemulapalli S.Initial experience with commercial transcatheter mitral valve repair in the United States.J Am Coll Cardiol2016;67:1129-40

[14] Eleid MF,Williams MR.Percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification.JACC Cardiovasc Interv2016;9:1161-74

[15] Eleid MF,Cabalka AK.Early outcomes of percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification.JACC Cardiovasc Interv2017;10:1932-42

[16] Attias D,Nappi F,Eleid MF.How to treat severe symptomatic structural valve deterioration of aortic surgical bioprosthesis: transcatheter valve-in-valve implantation or redo valve surgery?.Eur J Cardiothorac Surg2018;54:977-85

[17] Rumsfeld JS,Stough WG,Jacques LB.Insights from the early experience of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.JACC Cardiovasc Interv2015;8:377-81

[18] Carroll JD,Marinac-Dabic D.The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies.J Am Coll Cardiol2013;62:1026-34

[19] Feldman T,Elmariah S.EVEREST II InvestigatorsRandomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II.J Am Coll Cardiol2015;66:2844-54

[20] Ghoreishi M,Hobbs G.Repeat sternotomy: no longer a risk factor in mitral valve surgical procedures.Ann Thorac Surg2013;96:1358-65

[21] Patel NC,Seetharam K.Reoperative mitral valve surgery via sternotomy or right thoracotomy: A propensity-matched analysis.J Card Surg2019;34:976-82

[22] Suri RM,Dearani JA.Recurrent mitral regurgitation after repair: should the mitral valve be re-repaired?.J Thorac Cardiovasc Surg2006;132:1390-7

[23] Hu J,Cheng S.Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: A systematic review and meta-analysis.J Card Surg2018;33:508-19 PMCID:PMC6175121

[24] Yoon SH,Bleiziffer S.Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty rings.J Am Coll Cardiol2017;70:1121-31

[25] Nishida H,Kasegawa H,Yamazaki M.Causes of repair failure for degenerative mitral valve disease and reoperation outcomes.Eur J Cardiothorac Surg2018;53:1244-50

[26] Grover FL,Carroll JD.STS/ACC TVT Registry2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.J Am Coll Cardiol2017;69:1215-30

[27] Stone GW,Abraham WT.COAPT InvestigatorsTranscatheter mitral-valve repair in patients with heart failure.N Engl J Med2018;379:2307-18

[28] Obadia JF,Leurent G.MITRA-FR InvestigatorsPercutaneous repair or medical treatment for secondary mitral regurgitation.N Engl J Med2018;379:2297-306

[29] Nappi F.The use of subvalvular repair for functional mitral regurgitation.Ann Thorac Cardiovasc Surg2020;

[30] Nappi F,Santana O.Functional mitral regurgitation: an overview for surgical management framework.J Thorac Dis2018;10:4540-55 PMCID:PMC6106031

[31] Cheung A,Barbanti M.5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction.J Am Coll Cardiol2013;61:1759-66

[32] Nappi F,Chello M,Acar C.Double row of overlapping sutures for downsizing annuloplasty decreases the risk of residual regurgitation in ischaemic mitral valve repair.Eur J Cardiothorac Surg2016;49:1182-7

[33] Webb JG,Ye J.Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves.Circulation2010;121:1848-57

[34] Descoutures F,Maisano F.Transcatheter valve-in-ring implantation after failure of surgical mitral repair.Eur J Cardiothorac Surg2013;44:e8-15

[35] Seiffert M,Baldus S.Transcatheter mitral valve-in-valve implantation in patients with degenerated bioprostheses.JACC Cardiovasc Interv2012;5:341-9

[36] Borger MA,Rao V,David TE.Reoperative mitral valve replacement: importance of preservation of the subvalvular apparatus.Ann Thorac Surg2002;74:1482-7

[37] Gammie JS,Griffith BP.Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database.Ann Thorac Surg2009;87:1431-7; discussion 1437

[38] Simonato M,Ribeiro HB.Transcatheter mitral valve replacement after surgical repair or replacement: Comprehensive midterm evaluation of valve-in-valve and valve-in-ring implantation from the VIVID registry.Circulation2021;143:104-16

[39] Bapat VN.Mitral valve-in-valve, valve-in-ring, and valve-in-mitral annular calcification: Are we there yet?.Circulation2021;143:117-9

[40] Urena M,Brochet E,Iung B.Current indications for transcatheter mitral valve replacement using transcatheter aortic valves: Valve-in-valve, valve-in-ring, and valve-in-mitral annulus calcification.Circulation2021;143:178-96

[41] Kwedar K,Zajarias A,Vassileva CM.Outcomes of early mitral valve reoperation in the medicare population.Ann Thorac Surg2017;104:1516-21

[42] Kilic A,Han JJ.Redo mitral valve surgery following prior mitral valve repair.J Card Surg2018;33:772-7

[43] Romano MA,Pagani FD.Beating heart surgery via right thoracotomy for reoperative mitral valve surgery: a safe and effective operative alternative.J Thorac Cardiovasc Surg2012;114:334-9

[44] Anyanwu AC,Varghese R,Chikwe J.Re-repair of the mitral valve as a primary strategy for early and late failures of mitral valve repair.Eur J Cardiothorac Surg2014;45:352-7; discussion 357

[45] LaPar DJ,Isbell JM.Virginia Cardiac Surgery Quality InitiativeMitral valve repair rates correlate with surgeon and institutional experience.J Thorac Cardiovasc Surg2014;148:995-1003; discussion 1003

[46] David TE,McCrindle BW.Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease.Circulation2013;127:1485-92